Spiriva Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

A Study to Test the Combination of Tiotropium and Olodaterol Using the Respimat ® Inhaler in People With Chronic Obstructive Pulmonary Disease (COPD) Who Have Different Abilities to Inhale
Condition:   Pulmonary Disease, Chronic Obstructive Interventions:   Drug: Tiotropium + olodaterol;   Drug: Placebo Sponsor:   Boehringer Ingelheim Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 10, 2020 Category: Research Source Type: clinical trials

A Study to Test the Combination of Tiotropium and Olodaterol Using the Respimat ® Inhaler in People With Chronic Obstructive Pulmonary Disease (COPD) Who Have Different Abilities to Inhale.
Condition:   Pulmonary Disease, Chronic Obstructive Interventions:   Drug: Tiotropium + olodaterol;   Drug: Placebo Sponsor:   Boehringer Ingelheim Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 10, 2020 Category: Research Source Type: clinical trials

A Study to Test the Combination of Tiotropium and Olodaterol Using the Respimat ® Inhaler in People With Chronic Obstructive Pulmonary Disease (COPD) Who Have Different Abilities to Inhale
Condition:   Pulmonary Disease, Chronic Obstructive Interventions:   Drug: Tiotropium + olodaterol;   Drug: Placebo Sponsor:   Boehringer Ingelheim Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 9, 2020 Category: Research Source Type: clinical trials